FDA Drug Shortages

Current and Resolved Drug Shortages and Discontinuations Reported to FDA

Start Over | Back to Previous Screen

Deferoxamine Mesylate for Injection, USP
Status: Currently in Shortage
»Date first posted: 02/02/2018
»Therapeutic Categories: Hematology

Expand all

Fresenius Kabi USA, LLC (Reverified 05/03/2018)

Company Contact Information:
888-386-1300

Presentation Availability and Estimated Shortage Duration Related Information Shortage Reason (per FDASIA)
500 mg per vial, 10 mL vial (NDC 63323-597-10) Backordered. Next release anticipated May 2018. Check wholesaler inventory Demand increase for the drug
2 g per vial, 30 mL vial (NDC 63323-599-30) Backordered. Next release anticipated May 2018. Check wholesaler inventory Demand increase for the drug

Hospira, Inc. (Revised 05/22/2018)

Company Contact Information:
844-646-4398

Presentation Availability and Estimated Shortage Duration Related Information Shortage Reason (per FDASIA)
500 mg; Single Dose Glass Fliptop Vial (NDC 00409-2336-10) Next delivery & Estimated recovery: 2019 Shortage per Manufacturer: Manufacturing Delay

Dear Customer Letter

Other
2 g; Single Dose Glass Fliptop Vial (NDC 00409-2337-25) Limited supply Available. Next delivery & Estimated recovery: 2019 Shortage per Manufacturer: Manufacturing Delay

Dear Customer Letter

Other

Novartis (New 02/05/2018)

Company Contact Information:
888-669-6682

Presentation Availability and Estimated Shortage Duration Related Information Shortage Reason (per FDASIA)
Desferal Vials 500 mg cartons of 4 vials (NDC 0078-0467-91) Limited quantities available on allocation Check wholesaler inventories Demand increase for the drug

Note: If you need help accessing information in different file formats, see Instructions for Downloading Viewers and Players.
Language Assistance Available: Español | 繁體中文 | Tiếng Việt | 한국어 | Tagalog | Русский | العربية | Kreyòl Ayisyen | Français | Polski | Português | Italiano | Deutsch | 日本語 | فارسی | English